Riskpilot← Back to searchSign inGet full accessMEDICALIS TØNSBERG AS
ASActiveOrg 919789174Kammegaten 8, 3110 TønsbergGeneral medical practice activities · NACE 8621Est. 20175 employees
Revenue 2024
NOK 4,2M
+4% vs 2023
EBITDA margin
0.9%
-91% vs 2023
Equity ratio
70.3%
Financial strength
Net profit 2024
NOK -90K
-138% vs 2023
| Revenue | NOK 4,2M | +4% |
| EBITDA | NOK 36K | -91% |
| Net profit | NOK -90K | -138% |
| Total assets | NOK 1,1M | -12% |
| Equity | NOK 770K | -10% |
| Employees | 5 | — |
Legal name
MEDICALIS TØNSBERG AS
Org number
919789174
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
26. oktober 2017
Share capital
NOK 75 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drive legesenter, legevirksomhet, annen virksomhet innenfor helseområdet, konsulentvirksomhet, rådgivning og undervisning, kjøp/salg/utleie av fast eiendom, samt å eie og delta i andre selskaper med beslektet virksomhet.
Address
Kammegaten 8, 3110 Tønsberg
Phone
+4733331543
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 434 | 1 557 | 1 640 | 4 060 | 4 229 |
| Staff expenses | −838 | −844 | −1 032 | −1 725 | −1 815 |
| EBITDA | 1 | 26 | −121 | 398 | 36 |
| Depreciation & amort. | −0 | −0 | −5 | −97 | −128 |
| EBIT | 1 | 26 | −127 | 302 | −92 |
| Net financials | 0 | −0 | 30 | −26 | −1 |
| Profit before tax | 1 | 26 | −96 | 276 | −92 |
| Tax | −0 | 4 | −0 | 39 | −3 |
| Net profit | 1 | 22 | −96 | 236 | −90 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 321 | 215 | 322 | 1 248 | 1 096 |
| Equity | 22 | 45 | −52 | 860 | 770 |
| Long-term debt | 0 | 0 | 0 | 3 | 0 |
| Short-term debt | 299 | 170 | 374 | 385 | 326 |
| Total debt | 299 | 170 | 374 | 388 | 326 |
EBITDA margin
0.9%
This company
15.8%
Market median
-94% vs market
20202024
Equity ratio
70.3%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
-11.6%
This company
18.4%
Market median
-163% vs market
20202024
Net profit margin
-2.1%
This company
8.1%
Market median
-126% vs market
20202024
Asset turnover
3.86×
This company
1.12×
Market median
+245% vs market
20202024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
LE Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 | |
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDICALIS TØNSBERG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Edmund Gleditsch | Chief Executive Officer | 0 companies |
| Christian Smedsrud | Board of Directors | 0 companies |
| Alf Christian Olsen | Board of Directors | 0 companies |